Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

• 主要な著者: Hiroshi Nomoto (著者), Yuka Takahashi (著者), Yoshinari Takano (著者), Hiroki Yokoyama (著者), Kazuhisa Tsuchida (著者), So Nagai (著者), Aika Miya (著者), Hiraku Kameda (著者), Kyu Yong Cho (著者), Akinobu Nakamura (著者), Tatsuya Atsumi (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2023-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is an important common comorbidity in individuals with type 2 diabetes (T2DM). Although some glucagon-like peptide-1 receptor agonists (GLP-1RAs) have beneficial effects on NAFLD, the efficacy of once-weekly semaglutide has not been established. This was a s...